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Original ArticleAdiponectin release and insulin receptor
targeting share trans-Golgi-dependent
endosomal trafficking routesMaria Rödiger 1,2, Martin W. Werno 1,2, Ilka Wilhelmi 1,2, Christian Baumeier 1,2, Deike Hesse 1,2,
Nina Wettschureck 3, Stefan Offermanns 3, Kyungyeun Song 4, Michael Krauß 4, Annette Schürmann 1,2,*ABSTRACT
Objective: Intracellular vesicle trafficking maintains cellular structures and functions. The assembly of cargo-laden vesicles at the trans-Golgi
network is initiated by the ARF family of small GTPases. Here, we demonstrate the role of the trans-Golgi localized monomeric GTPase ARFRP1 in
endosomal-mediated vesicle trafficking of mature adipocytes.
Methods: Control (Arfrp1flox/flox) and inducible fat-specific Arfrp1 knockout (Arfrp1iAT/) mice were metabolically characterized. In vitro ex-
periments on mature 3T3-L1 cells and primary mouse adipocytes were conducted to validate the impact of ARFRP1 on localization of adiponectin
and the insulin receptor. Finally, secretion and transferrin-based uptake and recycling assays were performed with HeLa and HeLa M-C1 cells.
Results: We identified the ARFRP1-based sorting machinery to be involved in vesicle trafficking relying on the endosomal compartment for cell
surface delivery. Secretion of adiponectin from fat depots was selectively reduced in Arfrp1iAT/ mice, and Arfrp1-depleted 3T3-L1 adipocytes
revealed an accumulation of adiponectin in Rab11-positive endosomes. Plasma adiponectin deficiency of Arfrp1iAT/ mice resulted in dete-
riorated hepatic insulin sensitivity, increased gluconeogenesis and elevated fasting blood glucose levels. Additionally, the insulin receptor, un-
dergoing endocytic recycling after ligand binding, was less abundant at the plasma membrane of adipocytes lacking Arfrp1. This had detrimental
effects on adipose insulin signaling, followed by insufficient suppression of basal lipolytic activity and impaired adipose tissue expansion.
Conclusions: Our findings suggest that adiponectin secretion and insulin receptor surface targeting utilize the same post-Golgi trafficking
pathways that are essential for an appropriate systemic insulin sensitivity and glucose homeostasis.
 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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An appropriate adipose tissue function is a major determinant of
metabolic health. Beside storage and supply of energy, the adipose
tissue possesses a secretory capacity releasing a variety of bioactive
molecules into the circulation, such as adipokines, cytokines, and lipid
metabolites. To meet these secretory requirements, adipocytes crucially
rely on a sophisticated vesicle trafficking machinery. However, despite
that there is substantial knowledge about physiological effects of
secreted factors, such as leptin and adiponectin, precise intracellular
trafficking pathways and particular molecular components mediating
the targeting and release of bioactive molecules are still largely elusive.
Within the classical secretory pathway, transmembrane and soluble
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trafficking routes can diverge. In this context, the trans-Golgi network
(TGN) is conventionally regarded as the main cargo sorting station;
together with a broad range of accessory proteins, the TGN regulates
accurate packaging of cargo into the right transport vesicle and de-
livery along correct trafficking routes. The assembly of cargo-laden
vesicles at the TGN is initiated by the ARF family of small GTPases
consisting of ARF, SAR (secretion-associated and Ras-related), and
ARL (ARF-like) proteins [2]. Mammalian cells possess 6 ARF proteins
and more than 20 ARF-like proteins, whose intracellular roles are
poorly understood [3]. Among them, ARFRP1 (ADP-ribosylation factor-
related protein 1), which localizes in the activated GTP-bound form to
the TGN, has been functionally implicated in vesicle trafficking of VSVG
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Original Article[7], and the glucose transporters GLUT4 [8] and GLUT2 [9]. Further-
more, conditional adipocyte-specific deletion of Arfrp1 resulted in a
severe lipodystrophic phenotype of newborn mice underlining the
pivotal role of ARFRP1 for the development of functional adipose tissue
depots [10].
To explore the impact of ARFRP1 as part of the vesicle trafficking
machinery on the secretory capacity of mature adipocytes, we
generated a mouse model with an inducible fat-specific disruption of
the Arfrp1 gene (Arfrp1iAT/). Here, we demonstrate that the loss of
Arfrp1 from differentiated adipocytes diminishes adiponectin secretion
and plasma membrane localization of the insulin receptor associated
with detrimental effects on adipocyte metabolism and glucose ho-
meostasis. These findings were attributed to defective endosomal-
mediated exocytosis that was monitored in vitro following Arfrp1
suppression.
2. MATERIAL AND METHODS
2.1. Animals
In order to generate inducible adipocyte-specific Arfrp1 knockout an-
imals on a C57BL/6J background, transgenic mice carrying floxed
Arfrp1 alleles (Arfrp1flox/flox, N10 generation) [6] were crossed with mice
heterozygously expressing the CreERT2-transgene [11] under the
control of the adipocyte-specific adiponectin promotor (AdipoqCreERT2,
kindly provided by Prof. Dr. Stefan Offermanns, MPI, Bad Nauheim)
[12]. Mice were kept at a temperature of 22  2 C with a 12:12 h
lightedark cycle and ad libitum access to drinking water and
phytoestrogen-reduced standard diet (V1554-000 R/MH, Ssniff). At 5
weeks of age, male Arfrp1iAT/ and Arfrp1flox/flox mice received
tamoxifen (1 mg/d, SigmaeAldrich) by oral gavage for 5 consecutive
days continued by feeding a tamoxifen-containing, phytoestrogen-
reduced standard diet (400 mg/kg tamoxifen D.CRTAM400.R1, LAS-
vendi GmbH) until the end of the study (7 or 10 weeks of age). This
resulted in adipocyte-specific disruption of the Arfrp1 gene in
Arfrp1iAT/ mice. All animal experiments were approved by the ethics
committee of the State Office of Environment, Health and Consumer
Protection (Federal State of Brandenburg, Germany).
2.2. Body composition, blood glucose, pyruvate tolerance test
(PTT), and insulin response
Body composition of inducible adipocyte-specific Arfrp1 knockout mice
(Arfrp1iAT/) and control littermates (Arfrp1flox/flox) was determined
weekly by nuclear magnetic resonance (EchoMRITM-100H, EchoMRI
LCC). Blood glucose levels were measured using a CONTOUR XT
glucometer (Bayer). For PTT, 10-week-old mice were starved overnight
(18 h) before receiving an i.p. injection of sodium pyruvate (2 g/kg of
body weight; SigmaeAldrich). Blood glucose levels were measured at
indicated time points. For determination of insulin response in pe-
ripheral tissues, 10-week-old mice were fasted for 6 h before i.p.-
injected with either insulin (1 IU/kg body weight, Actrapid, Novo
Nordisk) or an equal volume of vehicle (physiologic saline, Fresenius
Kabi). After 20 min, mice were sacrificed and designated tissues
collected for western blot analysis of phosphorylated and total AKT
levels.
2.3. Ex vivo secretion and lipolysis assay
Gonadal (gon) and subcutaneous (sc) white adipose tissue (WAT) de-
pots were removed from 7-week-old Arfrp1iAT/ and Arfrp1flox/flox
mice, rinsed in prewarmed PBS, minced into small pieces (w10 mg),
and incubated in phenolred-free DMEM (PAN-Biotech) supplemented
with 4.5 g/l glucose, 25 mmol/l HEPES, 1 mmol/l sodium pyruvate,168 MOLECULAR METABOLISM 8 (2018) 167e179  2017 The Authors. Published by Elsevier GmbH. Thi4 mmol/l glutamine, 1% penicillin/streptomycin, and 2% fatty acid-free
BSA at 37 C and 5% CO2 for 24 h. Thereafter, supernatants were
collected, centrifuged (500 g for 5 min), and analyzed for adiponectin
and leptin concentration. To measure ex vivo lipolysis rates, gonWAT
explants were incubated in the above-mentioned medium in the
absence (basal lipolysis) or presence (stimulated lipolysis) of 10 mmol/l
isoproterenol (SigmaeAldrich) together with 1 mmol/l insulin (Roche)
when indicated for 2 h before detection of non-esterified fatty acids
(NEFA) in the supernatant. Fat explants were washed, collected and
lyzed for protein measurement. Adipokine and NEFA levels were
normalized to respective fat explant protein concentration.
2.4. Plasma and supernatant analyses
Designated adipokines were quantitatively assessed in plasma and
supernatant of fat explants using respective ELISA kits (DY1119,
MOB00, DY5430-05, DY1069, MWSP10, DY954, R&D Systems GmbH)
following the manufacturer’s instructions. Triglyceride, glycerol
(TR0100, SigmaeAldrich), and NEFA (NEFA-HR(2), Wako Chemicals
GmbH) levels were measured in plasma and fat explant supernatant
according to manufacturer’s protocol.
2.5. Subcellular fractionation of primary and 3T3-L1 adipocytes
Subcellular fractionation of isolated primary adipocytes from gonWAT
of 7-week-old Arfrp1iAT/ and Arfrp1flox/flox mice (5e6 mice pooled
per genotype) as well as 3T3-L1 adipocytes transfected with nt- (non-
targeting) or Arfrp1-siRNA was performed as described before [13].
2.6. Protein extraction and western blotting
Tissue lysates were prepared using RIPA buffer [50 mM TriseHCl (pH
7.2), 150 mMNaCl, 1 mM EDTA, 0.25% sodium deoxycholate, 1% Triton
X-100, 2 mM Na3VO4] supplemented with phosphatase inhibitor
(PhosSTOP, Roche) and protease inhibitor (cOmplete, Roche). Protein
concentration was measured using Pierce BCA Protein Assay Kit
(Thermo Scientific) according to the manufacturer’s protocol. Western
blot analysis of lysates and fractions from mouse tissue or 3T3-L1 ad-
ipocytes was performed as described previously [14]. The following
primary antibodies were applied overnight at 4 C: ARFRP1 (1:500;
Abcam, ab108199), insulin receptor b subunit (IRb; 1:500; Merck Mil-
lipore, GR36), IRS-1 (1:500; Cell Signaling, 3407), IRS-2 (1:500; Merck
Millipore, MABS15), AKT (1:1,000; Cell Signaling, 9272), pAKT (Ser473;
1:1,000; Cell Signaling, 9271), AMPKa (1:1,000; Cell Signaling, 2532),
pAMPKa (Thr172; 1:1,000; Cell Signaling, 2535), tFOXO (1:1,000, Cell
Signaling, 2880S), pFOXO (1:1,000, Cell Signaling 9464S), adiponectin
(1:500; Abcam, ab3455), calnexin (1:2,000; Abcam, ab22595), Rab11
(1/1,000; Thermo Fisher Scientific, 71e5300), a-tubulin (1:500;
SigmaeAldrich, T6199), and GAPDH (1:10,000; Ambion, AM4300). For
non-denaturing western blot analysis of adiponectin isoforms, equal
volumes of murine plasma samples were pre-diluted (1:30) and mixed
with 2 adiponectin sample buffer [3% SDS, 20% Glycerol, 50 mM Tris,
0.02% Bromophenol blue) before incubation at room temperature for 1 h
and separation in a precast gradient gel (4e15% Ready Gel TriseHCl
Gel, Bio-Rad). Corresponding HRP-conjugated secondary antibodies
(Dianova) were applied (1:20,000) for 1 h at room temperature before
targeted proteins were visualized using Amersham ECL Western Blotting
Detection kit (GE Healthcare).
2.7. Histology
Adipose tissue depots were fixed in 4% formaldehyde and embedded
in paraffin. Sections (2 mm) were deparaffinized, rehydrated, and
stained with hematoxylin and eosin (H&E) using a standard protocol
before dehydrated and mounted. Microscopic analysis was performeds is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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with the Keyence BZ-9000 Fluorescence Microscope and corre-
sponding BZ-II Analyzer software (Keyence International). Adipocyte
area of 3 histological images per animal and 3e5 mice per genotype
and age were assessed by applying an automated image analysis
software (WimAdipose, Wimasis GmbH).
2.8. RNA extraction and quantitative real-time PCR (qRT-PCR)
Total RNA from mouse tissues was extracted using RNeasy Mini Kit
(QIAGEN) according to manufacturer’s instructions. RNA samples were
reverse transcribed using the Moloney Murine Leukemia Virus Reverse
Transcriptase (M-MLV RT, Promega). Gene expression levels were
detected applying TaqMan Gene Expression Assays (Arfrp1
Mm01220415_g1, Adipoq Mm00456425_m1; G6pc Mm008393
63_m1, Pck1Mm01247058_m1, Eef2Mm01171434_g1) by using the
LightCycler 480 II/384 (Roche). Target gene expression was normal-
ized to Eef2 used as endogenous control.
2.9. Cell culture and si-RNA transfection
All cell lines were kept at 37 C and 5% CO2. 3T3-L1 cells (ATTC CL-
173) were cultured in IMDM (4.5 g/l glucose, PAN-Biotech) sup-
plemented with 10% newborn calf serum (NCS, PAN-Biotech). Dif-
ferentiation of confluent cells was induced by applying IMDM including
10% fetal bovine serum (FBS, PAN-Biotech), 1.2 mg/ml insulin (Roche),
0.5 mM 3-isobutyl-1-methylxanthine (IBMX, SigmaeAldrich), 0.25 mM
dexamethasone (SigmaeAldrich) and 2 mM rosiglitazone (Sigmae
Aldrich). At day 3 and day 4 medium was replaced by IMDM containing
10% FBS and 1.2 mg/ml insulin. Transfection with indicated siRNAs
was performed by electroporation at day 6 as previously described
[10], and cells were cultivated for further 96 h before used in different
experimental setups. HeLa (ATTC) and HeLa M-C1 cells were
cultured in DMEM (4.5 g/l glucose, Life Technologies) containing 10%
FCS and 50 mg/ml penicillin/streptomycin. When reaching 40% con-
fluency, cells were transfected with designated siRNAs by using Oli-
gofectamine (LifeTechnologies) according to manufacturer’s
instructions, re-seeded on matrigel-coated (BD-Bioscience) coverslips
the following day, and cultured for further 24 h before used in
immunofluorescence-based assays.
2.10. HeLa M-C1 secretion assay
For monitoring constitutive secretion, transfected HeLa M-C1 cells [15]
were washed with PBS and treated with 1 mM D/D solubilizer (Clon-
tech) diluted in Hank’s Balanced Salt Solution (HBSS, Gibco) to initiate
secretion of the reporter. At the indicated time points, cells were placed
on ice, washed twice with ice-cold PBS including 10 mM MgCl2, and
fixed with 4% paraformaldehyde (PFA) for 20 min at room temperature.
GFP intensity was quantified per cell, and all time points were
normalized to respective 0 min reflecting whole amount of reporter
located within the ER.
2.11. Transferrin recycling
Transfected HeLa cells and 3T3-L1 adipocytes were serum-starved for
1 h and incubated with 15 mg/ml Alexa568-labeled transferrin
(Alexa568-Tf, Life Technologies) at 37 C for 30 min to saturate
receptor-ligand uptake and recycling. After being washed with ice cold
phosphate-buffered saline (PBS) containing 10 mM MgCl2, cells were
acid washed at pH 5.3 (0.1 M Na-acetate, 0.5 M NaCl) for 1 min on ice
to remove surface-bound Tf (referred to 0 min), followed by washing
with ice cold PBS/MgCl2 and incubation with 1 mg/ml unlabeled Tf
(SigmaeAldrich) at 37 C for 20 min to allow receptor-ligand exocy-
tosis. Cells were fixed after 0 and 20 min with 4% PFA for 45 min at
room temperature. Alexa568-Tf intensity was quantified per cell andMOLECULAR METABOLISM 8 (2018) 167e179  2017 The Authors. Published by Elsevier GmbH. This is an op
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TfR exocytosis. For quantification of subcellular TfeTfR localization,
cells incubated with Alexa568-Tf at 37 C for 30 min were classified
into the following groups: overlapping TfeTfR signals distributed
throughout the entire cell (whole cell), primarily in the perinuclear
region (perinuclear) or at the cell periphery (tip). Counted cells per
classification were expressed as percentage of total number of cells.
2.12. Transferrin surface labeling and uptake
Transfected HeLa cells and 3T3-L1 adipocytes were serum-starved for
2 h and incubated with 15 mg/ml Alexa568-Tf for 50 min at 4 C to
block endocytosis. One set of cells was washed with ice cold PBS/
MgCl2 and fixed with 4% PFA for 45 min at room temperature to
determine surface-bound Alexa568-Tf as a measure of TfR surface
localization. Another set of cells was transferred to 37 C for 5 min
allowing TfeTfR endocytosis, followed by washing with PBS/MgCl2
and fixation with 4% PFA for 45 min at room temperature. Alexa568-Tf
intensity was quantified per cell and the rate of endocytosis was
calculated by the ratio of Tf uptake to Tf surface.
2.13. Immunocytochemistry
For immunocytochemical stainings of 3T3-L1 adipocytes, cells were
serum-starved for 4e6 h, fixed with 4% PFA for 10 min, rinsed with
PBS, washed with 50 mM NH4Cl (Roth) and subsequently per-
meabilized for 6 min with 0.2% saponin (SigmaeAldrich). After being
washed with 0.02% saponin, cells were incubated for 30 min in
blocking solution (2% BSA (SigmaeAldrich) in 0.02% saponin) before
application of primary antibodies diluted in blocking solution overnight
at 4 C. The following primary antibodies were used: ARFRP1 (1:100;
Abcam, ab108199), insulin receptor b subunit (1:50; Merck Millipore,
GR36), Rab11 (1:50; Thermo Fisher Scientific, 71-5300), g-adaptin
(1:100; BD Transduction Lab, 610385), LAMP1 (1:50; Abcam, [H4A3]
ab25630), leptin (1:1000, anti-rabbit, self-made), adiponectin (1:100;
Abcam, ab3455, ab22554), caveolin-1 (1:100; BD Transduction Lab,
610059). Thereafter, cells were incubated with corresponding
AlexaFluor-labeled secondary antibodies (1:200; Thermo Fisher Sci-
entific) and DAPI (1:1,000,000; Roche) diluted in blocking solution for
1 h at room temperature, followed by washing with 0.02% saponin and
mounting using Fluorescence Mounting Medium (Dako). Imaging and
quantification was performed with the Leica TCS SP8 X Laser Scanning
Confocal Microscope (Leica Microsystems) and the corresponding
image analysis software (Leica Application Suite X version 1.81).
Staining of fixed HeLa and HeLa M-C1 cells was performed as described
in [16] using the following primary antibodies: ARFRP1 (1:200; Abcam,
ab108199), transferrin receptor (1:300; Life Technologies, 13e6800),
GM130 (1:100; BD Transduction Lab, 610822) and AlexaFluor-labeled
secondary antibodies (1:200; Life Technologies). Cells were mounted
using Immu-Mount (Thermo Fisher Scientific) including 10 mg/ml DAPI
(Life Technologies). Stainings were analyzed and quantified using a
spinning disc confocal microscope (Ultraview ERS, Perkin Elmer) with
Volocity imaging software (Improvision, Perkin Elmer).
2.14. Statistical analysis
All data are reported as mean  SEM of at least three different ex-
periments, except when otherwise indicated. To compare differences
between two groups, paired or unpaired Student’s t-test or were
performed. Differences between two groups over the time were
evaluated using two-way ANOVA with Bonferroni’s correction for
multiple comparisons. Statistical analysis was performed with Prism 5
(GraphPad). Significance was accepted at *P  0.05, **P  0.01,
***P  0.001.en access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 169
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3.1. Adipocyte-specific deletion of Arfrp1 selectively reduces
adiponectin and adipsin secretion
As our previous studies have shown that the monomeric GTPase
ARFRP1 regulates intracellular trafficking of certain cargo molecules
and is indispensable for proper adipose tissue development, we aimed
to clarify the role of ARFRP1 on secretory processes in mature adi-
pocytes. We specifically deleted Arfrp1 in adipocytes by tamoxifen
treatment of 5-week-old Arfrp1flox/flox  AdipoqCreERT2 offspring
mice. As shown in Figure S1 tamoxifen treatment resulted in a specific
suppression of Arfrp1 expression in adipose tissues, other organs were
not affected. Two weeks following initiation of gene deletion, we
screened for the abundance of different adipokines in the plasma of 7-
week-old control (Arfrp1flox/flox) and inducible adipocyte-specific Arfrp1
knockout (Arfrp1iAT/) mice. Levels of adiponectin as well as adipsin
were significantly reduced in the circulation of mice lacking Arfrp1 in
adipose tissue depots, whereas other adipokines such as leptin and
resistin were not affected (Figure 1A). As multimerization of adipo-
nectin is described to be important for its secretion [17], we assessed
the three multimeric forms of adiponectin by non-denaturing western
blot analysis and observed similarly decreased abundance of all three
isoforms in the plasma of Arfrp1iAT/ compared to control mice
(Figure 1B). Intriguingly, adiponectin transcript levels (Adipoq) deter-
mined in gonadal and subcutaneous white adipose tissue (gonWAT,
scWAT) and in brown adipose tissue (BAT) were not altered between
the genotypes (Figure 1C), indicating that ARFRP1 acts on the level of
adiponectin secretion rather than influencing its expression. In addi-
tion, adiponectin and leptin secretion was measured ex vivo from
gonWAT and scWAT explants generated from 7-week-old Arfrp1iAT/
mice and control littermates. Consistent with in vivo results, adipo-
nectin released from fat explants of Arfrp1iAT/ animals was signif-
icantly lower than from those of control mice (gonWAT 55% and scWATFigure 1: Ablation of Arfrp1 in adipocytes selectively decreases adiponectin and ad
week-old Arfrp1iAT/ (white bars) and control (Arfrpflox/flox, black bars) mice (n ¼ 5e19 m
HMW: high molecular weight adiponectin. (C) Adiponectin transcript levels (Adipoq) determ
adipose tissue (BAT) of 7-week-old mice (n ¼ 3e6 mice per genotype). (D, E) Released le
and control mice (n ¼ 4e6 mice per genotype). All data are presented as mean  SEM
170 MOLECULAR METABOLISM 8 (2018) 167e179  2017 The Authors. Published by Elsevier GmbH. Thi59% of controls) (Figure 1D), whereas leptin release was not different
between the genotypes (Figure 1E). Thus, these data reveal that
ARFRP1 is specifically required for an appropriate adiponectin
secretion.
3.2. Loss of Arfrp1 leads to endosomal accumulation of
adiponectin
In order to define the subcellular distribution of adiponectin, isolated
adipocytes from gonWAT of 7-week-old Arfrp1flox/flox and Arfrp1iAT/
mice as well as 3T3-L1 adipocytes transfected with nt (non-targeting)-
or Arfrp1-siRNA were fractionated via differential centrifugation into
subcellular compartments. Purity of the different fractions was
assessed by respective marker proteins, e.g. SNAP23 for plasma
membranes (Figure S2). In accordance with the defective secretion of
adiponectin, it accumulated in the HDM fraction, containing ER (cal-
nexin, IRAP, Figure. S2) and endosomal (Rab11) membranes, of pri-
mary and 3T3-L1 adipocytes deficient of Arfrp1 (Figure 2AeD)
indicating either ER or endosomal sequestration of the adipokine.
Further characterization by immunocytochemical co-stainings of 3T3-
L1 adipocytes revealed that intracellular adiponectin was largely
immunopositive for recycling endosomal Rab11, an effect that was
even more pronounced following Arfrp1 suppression as evaluated by
Pearson’s correlation coefficient (Figure 2E,F). Overlap with lysosomal
LAMP1 and the TGN marker g-adaptin was limited (Figure 2E). An
intracellular accumulation of leptin after depletion of Arfrp1 in 3T3-L1
cells by specific siRNA treatment was not observed (Figure S3). Taken
together, these results suggest that defective cargo exit from endo-
somes may retard adiponectin release.
3.3. Loss of Arfrp1 specifically impairs endosomal-mediated
trafficking
Since adiponectin has been described to exit the cell via constitutive
and regulated pathways involving the endosomal compartment [18],ipsin secretion. (A) Circulating levels of indicated adipokines detected in plasma of 7-
ice per genotype). (B) Adiponectin isoforms measured in plasma of 7-week-old animals.
ined in gonadal and subcutaneous white adipose tissue (gonWAT, scWAT) and in brown
vels of adiponectin (D) and leptin (E) from gonWAT and scWAT explants of Arfrp1iAT/
, **P  0.01, ***P  0.001 by unpaired Student’s t-test.
s is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 2: Endosomal accumulation of adiponectin in adipocytes depleted of Arfrp1. (A, C) Abundance of adiponectin in subcellular fractions of isolated gonadal adipocytes
(gonWAT) from 7-week-old Arfrp1iAT/ (/) and Arfrpflox/flox mice (f/f ) (A) and 3T3-L1 adipocytes transfected with nt (non-targeting)- or Arfrp1-siRNA (C). (B, D) Signal in-
tensities were quantified by densitometric analysis and expressed as fold of control (Arfrp1flox/flox, si-nt) set to 1 (n ¼ 3 independent fractionations). Homog, homogenate; HDM,
high-density microsomes; LDM, low-density microsomes; PM, plasma membrane. (C) Transfected 3T3-L1 adipocytes were co-immunostained for adiponectin (red) with either
Rab11, g-adaptin or LAMP1 (green). Scale bar: 10 mm; magnification 5 mm. (F) Quantification of co-localization was calculated by Pearson’s correlation coefficient with at least
10e15 images analyzed per condition. Values are presented as mean  SEM, *P  0.05 by unpaired Student’s t-test.functionality of both secretory routes was analyzed in the presence and
absence of ARFRP1. To trace endocytic and recycling processes, the
transferrin receptor (TfR) and its ligand transferrin (Tf), were monitored
in nt- (non-targeting)- and Arfrp1-siRNA transfected HeLa cells. The
TfR is internalized after Tf binding at the cell surface and delivered toMOLECULAR METABOLISM 8 (2018) 167e179  2017 The Authors. Published by Elsevier GmbH. This is an op
www.molecularmetabolism.comearly endosomes. Thereafter, the Tf-TfR-complex recycles back to the
plasma membrane either directly from early endosomes (rapid recy-
cling) or via recycling endosomes (slow recycling) [19]. To dissect
ARFRP1 function in this context, transfected HeLa cells were incubated
with Alexa568-labeled Tf at 37 C for 30 min to allow receptor-liganden access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 171
Original Articleuptake and recycling. In Arfrp1-depleted cells endocytosed TfeTfR
markedly accumulated in close proximity to the plasma membrane,
primarily around the cellular tips, whereas control cells displayed Tfe
TfR signals throughout the entire cell or concentrated in the perinuclear
region as quantified from immunostainings (Figure 3A,B). This result
strongly pointed towards an impaired cargo exocytosis from endo-
somes when ARFRP1 is absent.
In order to monitor TfeTfR exocytosis, we incubated transfected HeLa
cells with Alexa568-Tf at 37 C for 30 min, removed surface-bound Tf
(referred to 0 min) and chased the receptor-ligand release for 20 min.
At time point 0 min, endocytosed Tf was markedly lower in Arfrp1-
depleted cells. However, after 20 min, Tf largely remained intracellu-
larly, whereas most of the Tf was successfully exocytosed from control
cells (Figure 3C). Quantification of the relative amount of released Tf
(44% vs. 18%) confirmed a significantly impaired exocytosis of Tf-TfR-
containing recycling vesicles from Arfrp1-knockdown compared to
control cells (Figure 3D).
To test whether this results in reduced TfR re-exposure at the plasma
membrane, we additionally examined cell surface localization and
endocytosis of the TfR and its ligand. Incubation of transfected HeLa
cells with Alexa568-conjugated Tf at 4 C resulted in Tf binding to cell
surface-localized TfR (Tf surface), followed by incubation at 37 C for
5 min allowing clathrin-mediated endocytosis of the Tf-TfR-complex
(Tf uptake). In fact, cell surface exposure of the TfR was strikingly
reduced by around 45% in cells deficient of ARFRP1 (Figure 3E,F).
Accordingly, Tf uptake was markedly lower (44%) upon Arfrp1 sup-
pression. However, the rate of TfeTfR endocytosis, calculated by the
ratio of Tf uptake to Tf surface, was unaltered (Figure 3F), substanti-
ating the notion that ARFRP1 affects endosomal trafficking at the level
of exocytosis rather than being required for endosomal internalization.
We next analyzed Tf uptake and recycling in 3T3-L1 adipoocytes in
which expression of Arfrp1 was suppressed by the specific si-RNA. As
demonstrated in Figure S4, the release of Tf in si-Arfrp1 transfected
3T3-L1 cells is reduced which indicates an impaired exocytotic ca-
pacity (Figure S4 A, B). Similar to results obtained in HeLa cells, the
relative uptake rate was not affected upon Arfrp1 knockdown
(Figure S4 D, E).
As adiponectin was also reported to exit the cell constitutively, we
evaluated anterograde cargo trafficking via the classical constitutive
secretory pathway by applying a HeLa M-C1-based secretion assay
[15]. This cell line stably expresses a GFP-tagged reporter construct
forming large aggregates, which are trapped within the ER under basal
conditions. After the addition of a specific ligand (D/D solubilizer),
aggregates are dissolved, allowing the reporter to be transported
through the classical secretory pathway in order to be released from
cells which was monitored by immunofluorescence microscopy.
Although post-Golgi trafficking appeared to be delayed, constitutive
secretion in general was intact in Arfrp1-depleted HeLa M-C1 cells
(Figure S5). Taken together, these data demonstrate that ARFRP1 is
required for efficient exocytosis from endosome-derived recycling
vesicles, thereby potentially promoting cell surface delivery of certain
cargo released via the endosomal system such as adiponectin.
3.4. Lack of Arfrp1 reduces cell surface localization of the insulin
receptor
Similar to TfR, the insulin receptor is a transmembrane receptor partially
undergoing endocytic recycling following ligand binding and internali-
zation [20,21]. As we detected lower cell surface exposure of the TfR in
response to Arfrp1 suppression, we evaluated the localization of the
insulin receptor in adipocytes of 7-week-old Arfrp1iAT/ and control
mice (2 weeks of tamoxifen treatment). Notably, the amount of insulin172 MOLECULAR METABOLISM 8 (2018) 167e179  2017 The Authors. Published by Elsevier GmbH. Thireceptor analyzed in plasma membrane fractions of isolated primary
adipocytes from Arfrp1iAT/ mice was significantly reduced by about
50% compared to plasma membranes of control littermates
(Figure 4A,B). At the same time, total insulin receptor levels measured in
gonWAT lysates were unaffected (Figure 4C,D). However, following
longer Arfrp1 deletion, at the age of 10 weeks (5 weeks of tamoxifen
treatment), the mature receptor was markedly reduced in gonWAT of
Arfrp1iAT/ animals while pro-insulin receptor levels showed no dif-
ference between the genotypes, suggesting that insulin receptor mis-
targeting was followed by its accelerated degradation rather than
resulting from transcriptional downregulation. (Figure 4C,D). We
confirmed the in vivo data by analyzing the subcellular distribution of the
insulin receptor in differentiated 3T3-L1 adipocytes. In agreement with
membrane fractionations of primary adipocytes, immunocytochemical
co-stainings revealed less cell surface localization of the insulin receptor
in response to Arfrp1 suppression (Figure 4E). Accordingly, co-
localization of the insulin receptor with the plasma membrane marker
caveolin-1, evaluated by Pearson’s correlation coefficient, was signifi-
cantly decreased in Arfrp1-depleted cells (Figure 4F). Taken together,
we demonstrate that in addition to the TfR in HeLa cells, the insulin
receptor in adipocytes was markedly reduced at the plasma membrane,
suggesting that ARFRP1 promotes efficient receptor recycling back to
the cell surface by regulating endosomal-mediated exocytosis.
3.5. Adipocyte-specific deletion of Arfrp1 affects insulin response,
lipolytic activity, and expandability of adipose tissue
As we found that ARFRP1 is required for an efficient cell surface
exposure of the insulin receptor, we tested if adipose insulin sensitivity
is impaired in Arfrp1iAT/ mice. For this purpose, 10-week-old ani-
mals were acutely injected with insulin or vehicle (NaCl) and sacrificed
20 min later in order to assess the insulin response of white and brown
adipose depots (WAT, BAT). Arfrp1iAT/ mice revealed a markedly
blunted insulin-stimulated AKT phosphorylation in both fat depots,
when compared to control littermates (Figure 5AeC). Furthermore,
elevated triglyceride, NEFA, and glycerol levels detected in plasma of
10-week-old Arfrp1iAT/ mice pointed towards an impaired insulin-
mediated suppression of adipocyte lipolysis (Figure 5DeF). To eval-
uate whether impaired adipose insulin signaling of Arfrp1iAT/ mice
caused the alterations in plasma lipid levels, we analyzed ex vivo
lipolytic activity of gonWAT explants generated from 7-week-old
Arfrp1flox/flox and Arfrp1iAT/ mice. We found that NEFA release from
fat biopsies originating from Arfrp1iAT/ mice was significantly higher
than from those of control mice indicating an elevation of basal lipolysis
(Figure 5G). Treatment with the b3-adrenergic receptor agonist
isoproterenol markedly stimulated NEFA mobilization from explants of
both genotypes, however to a lesser extent from those of Arfrp1iAT/
mice. The addition of insulin failed to suppress isoproterenol-induced
lipolysis in explants of Arfrp1iAT/ mice (Figure 5G) confirming that
insulin-mediated inhibition of adipose lipolytic activity was blunted in
Arfrp1iAT/ animals. We also detected ATGL in lysates of control and
Arfrp1iAT/ mice, because insulin has been demonstrated to sup-
press the expression of the rate-limiting lipolytic enzyme ATGL [22].
The western blots showed a tendency towards higher ATGL levels in
gonWAT samples of Arfrp1iAT/ in comparison to control mice
(p ¼ 0.098), which is in agreement with the increased basal lipolytic
rate observed in these mice (Figures S8A and B). In addition, pre-
sumably due to an impaired insulin receptor signaling, Arfrp1iAT/
mice revealed decreased phospho-FOXO1 levels (Figures S8C and D).
In line with that, and with reference to the lipodystrophic phenotype of
the conditional fat-specific Arfrp1 knockout mouse [10], expansion of
adipose tissue was found to be impaired in Arfrp1iAT/ mices is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 3: Suppression of Arfrp1 results in impaired endosomal-mediated secretion at the level of exocytosis. (A) Distribution of the transferrin receptor (TfR, green) and its
ligand transferrin (Tf, red) was analyzed in HeLa cells transfected with nt (non-targeting, black bars)- or Arfrp1-siRNA (white bars) following 30 min of Alexa568-Tf incubation at
37 C. Cells were co-stained for ARFRP1 (pink). Scale bar: 20 mm. White arrowheads indicate TfeTfR signals in the tip region. (B) TfeTfR distribution was classified and counted
cells per classification were expressed as percentage of total number of cells. (C, D) TfeTfR exocytosis was assessed in transfected HeLa cells. At indicated time points, cells were
fixed and stained for ARFRP1 (pink) (C). Alexa568-Tf intensity was quantified per cell and expressed as fold of control cells (0 min) set to 1. The relative amount of released Tf was
calculated as a measure of TfeTfR exocytosis (D). (E, F) Tf surface and uptake was analyzed in transfected HeLa cells. Before and after temperature switch, cells were fixed and
co-stained with anti-TfR (green) and anti-ARFRP1 (pink) (E). Alexa568-Tf intensity was quantified per cell and expressed as fold of control cells (4 C) set to 1. The ratio between Tf
uptake to Tf surface was calculated as a measure of TfeTfR endocytosis (F). For all stainings DAPI (blue) was used to visualize nuclei. Scale bar: 20 mm. All quantifications
represent mean  SEM from 3 to 4 independent experiments each with 10e25 images analyzed per condition, n.s. - not significant, *P  0.05 by unpaired Student’s t-test (B, D,
F) or by paired t-test (D, F).
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Figure 4: Adipocyte-specific depletion of Arfrp1 leads to diminished plasma membrane localization of the insulin receptor. (A, B) Abundance of the insulin receptor was
assessed by immunoblotting using an antibody against the b subunit (IRb) in isolated plasma membrane (PM) fractions of gonadal white adipocytes from 7-week-old Arfrp1iAT/
(white bars) and control mice (Arfrp1flox/flox, black bars) (A). Band intensities were quantified by densitometric analysis and expressed as fold of control set to 1 (n ¼ 3 independent
fractionations) (B). (C, D) Analysis of insulin receptor protein levels in gonWAT lysates from 7- and 10-week-old mice by western blotting (C). Signal intensities were quantified by
densitometric analysis and expressed as fold of control set to 1 (n ¼ 4e5 mice per genotype) (D). (E) Co-immunostaining of 3T3-L1 adipocytes transfected with nt (non-targeting)-
or Arfrp1-siRNA with antibodies against IRb (green) and ARFRP1 (white). DAPI (blue) was used to visualize nuclei. Scale bar: 10 mm. (F) Co-localization between insulin receptor
and caveolin-1 was quantified by Pearson’s correlation coefficient (n ¼ 3 independent transfections). All data are presented as mean  SEM, *P  0.05 by paired t-test (B) or by
unpaired Student’s t-test (D, F).
Original Article(Figure 5J). As a consequence, body weight gain of these animals was
moderately reduced (Figure 5I), whereas development of lean mass
was indistinguishable between the genotypes (Figure S6). Histological
examination of gonWAT and scWAT sections from 7- and 10-week-old
mice (Figure 5L, M) and subsequent quantification of gonadal adipo-
cyte area confirmed that adipocyte enlargement by hypertrophic
growth was blunted in Arfrp1iAT/ mice (Figure 5K). From these data,
we conclude that reduced cell surface localization of the insulin re-
ceptor leads to diminished adipose insulin sensitivity, which, in turn,
promotes adipocyte lipolytic activity resulting in attenuation of adipose
tissue growth in Arfrp1iAT/ mice. We furthermore conclude that
adiponectin release and insulin receptor recycling utilize the same
post-Golgi trafficking pathways in adipocytes.
3.6. Adipocyte-specific disruption of Arfrp1 impairs liver insulin
signaling and hepatic control of glucose homeostasis
Since we demonstrated that ARFRP1 is necessary for an adequate
secretion of adiponectin, which has insulin-sensitizing properties on
peripheral tissues such as liver and skeletal muscle [23,24], we
assessed insulin sensitivity of these particular tissues. We found that174 MOLECULAR METABOLISM 8 (2018) 167e179  2017 The Authors. Published by Elsevier GmbH. Thiinsulin-stimulated AKT-phosphorylation was dramatically reduced in
livers of Arfrp1iAT/ mice, whereas insulin sensitivity of skeletal
muscle was unaffected (Figure 6AeC). Adiponectin has been
described to enhance hepatic insulin response by an increase in
phosphorylation and activity of AMPK [24]; however, the level of
phosphorylated AMPK assessed in liver lysates was not different be-
tween the genotypes (Figure S7). Beside AMPK-related effects, adi-
ponectin was shown to sensitize the liver towards the action of insulin
via a selective upregulation of hepatic IRS-2 protein expression [25].
Indeed, we found that IRS-2 protein was significantly diminished in
liver lysates of Arfrp1iAT/ compared to control mice (Figure 6D,E),
supporting our assumption that deficiency of circulating adiponectin
deteriorates hepatic insulin sensitivity of Arfrp1iAT/ animals via a
selective reduction in hepatic IRS-2 content. In contrast, protein
expression of IRS-1 and insulin receptor showed no alterations be-
tween the genotypes (Figure 6D,E). Since insulin signaling in the liver
largely controls hepatic glucose production, we performed pyruvate
tolerance tests following 18 h of fasting. As shown in Figure 6F,G,
Arfrp1iAT/ animals displayed considerably higher blood glucose
excursions than control littermates, indicating that gluconeogenesiss is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 5: Disruption of Arfrp1 in adipocytes affects insulin sensitivity, lipolytic rate and expansion of adipose tissue. (A, B) In vivo AKT-phosphorylation in subcutaneous
white (A) and brown (B) adipose tissue (WAT, BAT) of 10-week-old Arfrp1iAT/ (/; white symbols) and Arfrpflox/flox mice (f/f, black symbols) 20 min after injection of insulin (Ins,
1 IU/kg body weight, n ¼ 3e5 mice per genotype) or vehicle (NaCl, n ¼ 2 mice per genotype). (C) Band intensities (insulin treatment) were quantified by densitometric analysis,
and the ratio of phosphorylated (pAKT) to total AKT (tAKT) levels was expressed as fold of control set to 1. (DeF) Levels of triglycerides (D), non-esterified fatty acids (NEFA) (E) and
glycerol (F) were measured in plasma of 10-week-old mice (n ¼ 10 mice per genotype). (G) Ex vivo lipolysis was assessed under indicated conditions in gonadal WAT explants
generated from 7-week-old animals by determining NEFA concentration in the supernatant. Data were normalized to corresponding protein content and expressed as fold of
untreated controls set to 1 (n ¼ 7e8 mice per genotype). (I, J) Gain of body weight (I) and fat mass (J) of Arfrp1iAT/ and control mice (n ¼ 14e17 mice per genotype). The
arrows indicate start of tamoxifen treatment. (K) Quantification of gonadal adipocyte area from 7- and 10-week-old mice was performed by an automated image analysis software
(WimAdipose, Wimasis GmbH) (n ¼ 3e5 mice per genotype and age, each with at least 3 independent histological sections). (L, M) Representative H&E stainings of gonadal and
subcutaneous white adipose tissue sections from 7- (L) and 10- (M) week-old animals. Scale bar: 60 mm. Arrowheads indicate areas with smaller adipocytes. All values represent
mean  SEM, n.s. - not significant, *P  0.05, **P  0.01, ***P  0.001 by unpaired Student’s t-test (C-G, K) or by two-way ANOVA with Bonferroni’s post-test for multiple
comparison (I, J).
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Figure 6: Loss of adipocyte-specific Arfrp1 results in deteriorated liver insulin sensitivity, increased hepatic glucose production, and elevated fasting blood glucose
levels. (A, B) Western blot analysis of phosphorylated (pAKT) and total AKT (tAKT) levels in liver (A) and quadriceps (B) of 10-week-old Arfrp1iAT/ (white symbols) and control
mice (Arfrp1flox/flox, black symbols) following injection with insulin (Ins, 1 IU/kg body weight, n ¼ 3e5 mice per genotype) or vehicle (NaCl, n ¼ 2 mice per genotype). (C) Band
intensities (insulin treatment) were quantified by densitometric analysis, and the ratio of pAKT to tAKT was expressed as fold of control set to 1. (D, E) Expression of indicated
proteins was determined in liver lysates of 10-week-old animals via immunoblotting (D). Signal intensities were quantified by densitometric analysis and expressed as fold of
control set to 1 (n ¼ 3e5 mice per genotype) (E). (F) Ten-week-old mice were subjected to pyruvate tolerance tests (PTT), and blood glucose concentration was determined at
indicated time points (n ¼ 17e20 animals per genotype). (G) The area under the curve (AUC) is depicted for blood glucose. (H) Transcript levels of gluconeogenic genes (G6pc,
Pck1) were determined by qRT-PCR in livers of 10-week-old animals (n ¼ 4e18 mice per genotype) after 6 h of fasting. (I) Blood glucose concentration was measured in 10-
week-old mice at indicated time points (n ¼ 10e17 mice per genotype). All data represent mean  SEM, *P  0.05, **P  0.01, ***P  0.001 by unpaired Student’s t-test (C, E,
G-I) or by two-way ANOVA with Bonferroni’s post-test for multiple comparison (F).
Original Articlewas increased in these mice. Accordingly, mRNA expression of G6pc
was significantly higher in livers of 6 h fasted Arfrp1iAT/ than in
control mice further arguing for an elevation in hepatic glucose pro-
duction via gluconeogenesis (Figure 6H). As a consequence, blood
glucose concentration was significantly higher in mice lacking Arfrp1 in
adipose tissue after 6 h of fasting, an effect which became even more
pronounced after 16 h of food deprivation (Figure 6I). However, it
cannot be excluded that the elevated blood glucose concentration in
Arfrp1iAT/ mice is also a consequence of an impaired glucose up-
take by skeletal muscle and adipose tissue. Taken together, the pre-
sent data strongly suggest that the impaired release of adiponectin
from Arfrp1-deficient adipose tissue led to perturbations in the adipoe
liver axis. This was characterized by an impaired hepatic insulin
sensitivity associated to decreased IRS-2 protein levels, which, in turn,
resulted in elevated hepatic gluconeogenesis and increased blood
glucose levels in Arfrp1iAT/ mice under fasting conditions.
4. DISCUSSION
In the current study, we have identified adiponectin secretion and in-
sulin receptor surface targeting to largely rely on the action of functional176 MOLECULAR METABOLISM 8 (2018) 167e179  2017 The Authors. Published by Elsevier GmbH. ThiARFRP1 at the trans-Golgi in mature adipocytes. Both cargo molecules
utilize trans-endosomal routes for cell surface delivery resulting in either
secretion (adiponectin) or plasma membrane exposure (insulin recep-
tor). Mice with an inducible deletion of Arfrp1 in adipocytes reveal
significantly less adiponectin release and insulin receptor surface
localization causing hepatic insulin resistance and impaired glucose
homeostasis as well as reduced adipose insulin signaling promoting
lipolytic activity and inhibiting adipose tissue expansion.
Adiponectin, a classically secreted adipokine depending on proper ER/
Golgi function, has been reported to exit the cell via endosomal-mediated
secretion pathways [26]. Initially, folding and assembly of adiponectin
into higher-order complexes (trimer, hexamer, high-molecular weight
adiponectin) involves a complex set of regulatory steps in the ER and
Golgi apparatus [17,27e29]. Once adiponectin reaches the TGN, a pool
of adiponectin molecules is packaged into GGA1 (Golgi-localized,
gamma adaptin ear containing, ARF-binding protein 1)-coated vesicles
for further delivery to endosomes [30]. GGA1 is a monomeric coat
adapter known to be activated at the trans-Golgi network where it
mediates the sorting of selected cargo-containing transport vesicles
from the TGN to endosomes [31]. In agreement with that, cellular adi-
ponectin has been shown to partially co-localize with Rab11, a marker ofs is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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recycling endosomes as well as with Rab5 and EEA1 (early endosome
antigen 1) representing early endosomes [18,32].
Based on assays employing the transferrin receptor (TfR) and its ligand
transferrin (Tf), which have been widely used to trace endocytic and
recycling processes, we demonstrated in the current study ARFRP1 to
be critically involved in the process of endosomal-mediated exocytosis
(Figure 3C,D). Consistently, adipocyte-specific ablation of Arfrp1 in
mice (Figure 2A,B) or 3T3-L1 cells (Figure 2C,D) promoted an endo-
somal enrichment of adiponectin, showing increased co-localization
with Rab11-positive recycling endosomes when Arfrp1 was depleted
in 3T3-L1 adipocytes (Figure 2E,F). In accordance with accumulating
adiponectin in fat cells, the endosomal transit of the TfeTfR complex
was impaired in Arfrp1-deficient HeLa cells as indicated by accumu-
lation of TfeTfR at the cell periphery in these cells (Figure 3A,B). From
these data, we conclude that the loss of Arfrp1 in adipocytes selectively
impairs secretion of adiponectin via trans-endosomal routes. Further
supportive of this assumption is the finding that a fraction of intra-
cellular adiponectin overlaps with TfR-positive membranes in 3T3-L1
adipocytes, implying that adiponectin release occurs via the TfR-
positive endosomal compartment [26]. Beside this, adiponectin was
also described to exit the cell constitutively [18]. However, this route of
secretion is principally intact in Arfrp1-depleted cells (Figure S5) and
might explain the residual adiponectin that could be detected in plasma
and fat explant supernatant of Arfrp1iAT/ mice.
Notably, both circulating adiponectin and adipsin were equally dimin-
ished by about 50% in Arfrp1iAT/mice consistent with several studies
reporting overlapping trafficking routes for their secretion from 3T3-L1
cells which was strikingly inhibited upon ablation of TfR-positive endo-
somes [18,26,33]. In agreement with an unaffected leptin secretion
(Figure 1A,E), post-Golgi traffic of leptin was shown to occur indepen-
dently of intact endosomal compartments as their inactivation did not
compromise leptin release from 3T3-L1 or primary rat adipocytes [18].
The fact that deletion of Arfrp1 reduces the plasma levels of adipo-
nectin and adipsin could indicate that the observed phenotype is the
consequence of both adipokines. However, the Spiegelman group
recently reassessed the metabolic role of adipsin [34] showing that
adipsin has an impact on sustaining insulin production and/or secretion
particularly under conditions of diet-induced obesity. As mice in the
present study received a standard diet and additionally showed no
obvious phenotype concerning plasma insulin levels, further in-
vestigations focused on adiponectin.
Interestingly, the previously generated conditional fat-specific Arfrp1
knockout mouse did not exhibit reduced plasma adiponectin levels, as
observed in the current study. However, conditional knockout mice
failed to develop functional WAT and only displayed residual BAT, still
expressing a considerable amount of Arfrp1, which might represent
the exclusive adiponectin source in these mice [10]. Different mouse
models of genetic adiponectin ablation demonstrated a selective he-
patic insulin resistance without any impairments of insulin sensitivity in
skeletal muscle, even under standard diet-fed conditions [25,35,36]. In
this context, hypoadiponectinemia was shown to reduce hepatic IRS-2
expression [20,31]. In particular, adiponectin transiently increases
macrophage-derived plasma IL-6 levels, which, in turn, activate he-
patic STAT3 to induce hepatic IRS-2 expression and enhance insulin
sensitivity in the liver [20]. Intriguingly, IRS-2 largely determines insulin
signaling in the liver during fasting, thereby substantially controlling
hepatic glucose production via gluconeogenesis [21].
These findings conclusively connect the plasma adiponectin decline to
the impaired hepatic control of glucose homeostasis in these animals.
Following defective endosomal-mediated exocytosis, cell surface
exposure of the TfR was substantially diminished in Arfrp1-depletedMOLECULAR METABOLISM 8 (2018) 167e179  2017 The Authors. Published by Elsevier GmbH. This is an op
www.molecularmetabolism.comHeLa cells (Figure 3E,F). Similarly, the insulin receptor was less
abundant at the plasma membrane in primary adipocytes (Figure 4A,B)
and 3T3-L1 cells (Figure 4E,F) deficient of Arfrp1. After binding of
insulin to its receptor and internalization, receptor-ligand complexes
are directed for either lysosomal degradation, a way of downregulating
signal reception, or receptors are sorted for reinsertion into the plasma
membrane [37,38]. In this context, it was demonstrated that preven-
tion of insulin receptor recycling resulted in an accelerated shunting to
a degradative pathway, thereby reducing the amount of total cellular
receptors [21]. Indeed, 10-week-old Arfrp1iAT/ mice revealed sub-
stantially diminished protein levels of the mature receptor in gonWAT
lysates, suggesting that impaired re-exposure at the cell surface, as
assessed by lower plasma membrane abundance in adipocytes from
7-week-old Arfrp1iAT/ mice, was accompanied by enhanced re-
ceptor degradation (Figure 4C,D).
As expected, the insulin receptor surface deficiency resulted in reduced
adipose insulin sensitivity (Figure 5AeC). By promoting triglyceride
synthesis and inhibiting lipolysis, insulin signaling enhances overall lipid
storage in adipocytes. Consistently, adipose tissue explants from
Arfrp1iAT/ mice exhibited an increased basal lipolytic rate as well as
impaired insulin-mediated suppression of isoproterenol-stimulated
lipolysis (Figure 5G). Insufficiently repressed lipolysis consequently
associated with an impaired hypertrophic growth of adipose tissue de-
pots in Arfrp1iAT/ mice (Figure 5J). Collectively, these findings
demonstrate the requirement of ARFRP1 for mature adipocytes to
maintain proper insulin action, thereby determining adipose tissuemass.
The importance of insulin in controlling lipolysis and fat mass is further
emphasized by mouse models with alterations in the insulin signaling
pathway of adipocytes. For example, mice with a tamoxifen-inducible
knockout of the insulin receptor in mature adipocytes reveal a sub-
stantial decrease of adipose tissue mass due to increased lipolysis and
adipocyte apoptosis resembling most of the features of the Arfrp1iAT/
 phenotype [39]. Furthermore, the sorting receptor SORLA was
recently identified to interact with the insulin receptor in adipocytes
facilitating its redirection to the cell surface and enhancing insulin
signal reception. Accordingly, mice overexpressing SORLA specifically
in adipocytes revealed higher insulin receptor surface levels and
decreased lipolysis, which promotes the acquisition of fat tissue and
exacerbates diet-induced obesity, while SORLA knockout mice showed
excessive lipolysis and a reduction in WAT mass [40].
Notably, numerous genetic variants encoding proteins involved in ve-
sicular transportation (e.g. ARL15, Hip1, Rab3gap1) have been iden-
tified by genome-wide association studies (GWAS) as being associated
with type 2 diabetes-related traits in humans [41]. These findings
further highlight the relevance of functional intracellular vesicle traf-
ficking in preserving metabolic health.
5. CONCLUSIONS
Collectively, the present study suggests that adiponectin secretion and
insulin receptor surface targeting share the same post-Golgi trafficking
pathways which are regulated by the ARFRP1-based sorting ma-
chinery. In this regard, our results underline the pivotal role of ARFRP1
for mature adipocytes in maintaining adipose tissue mass and glucose
homeostasis.
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